جميع الدراسات
مكتملتداخلي

Biologically adaptive radiotherapy for oropharyngeal cancer

Radiotherapy is a standard treatment for throat cancer, but sometimes the tumour comes back in the same spot. Doctors want to see if adapting radiotherapy to each patient can improve cure rates. In this study, patients have a specialised MRI scan before starting treatment and another scan after two weeks of radiotherapy. These scans show how well the cancer is responding. If the tumour is shrinking as hoped, patients carry on with standard radiotherapy. If the cancer is responding more slowly, doctors increase the radiation dose for the remaining four weeks. Researchers want to see if this tailored approach is practical to run in hospitals and whether it keeps cancer away without causing too many extra side effects. Patients are monitored closely throughout treatment to support their recovery and quality of life.

نظرة سريعة

الحالة
مكتمل
الراعي
خدمات الصحة الوطنية في غلاسكو الكبرى وكلايد
الهدف من التسجيل
20
ابدأ
24 أغسطس 2023
التاريخ المتوقع للانتهاء
31 أكتوبر 2025

ما هو موضوع هذه الدراسة؟

Oropharyngeal cancer is a type of head and neck cancer that affects the back of the throat, including the tonsils and the base of the tongue. The standard treatment is usually a six-week course of radiotherapy. While this cures many people, some tumours do return in the exact same place. Doctors know that giving a higher radiation dose can destroy stubborn cancer cells, but giving higher doses to everyone is unnecessary and causes extra side effects.

To find the right balance, researchers are using a technique called diffusion-weighted MRI. This special scan looks at how water molecules move inside tissues, which reveals whether cancer cells are dying. Patients have one scan before starting radiotherapy and another after two weeks of treatment. This allows doctors to see very early on how the cancer is reacting.

If the two-week scan shows the tumour is shrinking well, the patient continues with standard radiotherapy. If the scan suggests the cancer is resisting the treatment, the care team changes the treatment plan to deliver a higher, more targeted dose of radiation for the remaining weeks.

Because this personalised method is new, this study is testing how smoothly these mid-treatment adjustments can be made in regular hospital practice. Researchers are also tracking side effects and daily wellbeing to ensure the higher dose is safe and manageable for patients.

النقاط الرئيسية

  • The trial tests whether adjusting radiotherapy halfway through treatment improves cure rates for throat cancer.
  • Special MRI scans are taken before treatment and after two weeks to see how the tumour is responding.
  • Only patients whose tumours are slow to shrink will receive an increased dose of radiotherapy.
  • The study takes place at the Beatson West of Scotland Cancer Centre in the UK.
  • Taking part is voluntary, and you can leave the study at any time without affecting your NHS care.

من قد يكون مؤهلاً؟

This trial is open to adults aged 18 and over who have been diagnosed with advanced throat cancer (stages III, IVa, or IVb) that has not spread to distant parts of the body. It is designed for people who are due to receive radiotherapy on its own as their primary curative treatment, rather than having surgery or chemotherapy first.

Because different types of throat cancer respond differently to treatment, this study focuses on specific groups: people whose cancer is not linked to the human papillomavirus (HPV), or people with HPV-positive cancer who also have a heavy history of smoking.

You will not be able to join if your cancer started outside the back of the throat, if you have already had surgery to remove the tumour, or if you have received head and neck radiotherapy in the past. People who cannot safely have an MRI scan (for example, due to certain metal implants) are also unable to take part.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. I am aged 18 or over.
  2. I have been diagnosed with stage III or IV throat (oropharyngeal) cancer.
  3. My cancer has not spread to distant parts of my body.
  4. I am scheduled to have radiotherapy alone (without chemotherapy or prior surgery) as my main treatment.
  5. I am able to safely have MRI scans.
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

Taking part lasts for the duration of your radiotherapy, which is usually six weeks, followed by regular check-ups. Before treatment begins, you will have a specialised MRI scan, routine blood tests, and possibly a small tissue sample (biopsy) taken. You will then start your daily radiotherapy sessions from Monday to Friday.

After two weeks of treatment, you will have a second MRI scan. If your tumour is responding well, you will finish your treatment using the standard radiotherapy plan. If the scan shows the tumour needs extra treatment, your medical team will design a new plan giving a higher radiation dose over the final four weeks. Throughout your care and during recovery, you will attend regular review appointments to discuss side effects, check your throat, and complete short questionnaires about your daily wellbeing.

المخاطر والفوائد المحتملة

A potential benefit of joining this study is that receiving a higher dose of radiation could give you a better chance of curing the cancer or stopping it from coming back. You will also receive extra monitoring and close support from the specialist research team. However, radiotherapy to the head and neck causes well-known side effects, including severe tiredness, painful mouth sores, skin redness, dry mouth, taste loss, and difficulty swallowing (which may require a temporary feeding tube). A higher dose might slightly increase the risk or severity of these side effects, although modern planning helps shield healthy tissue. Joining the trial is entirely voluntary, and you can withdraw at any point without your standard NHS treatment being affected.

المواقع (1)

بعض مواقع الأماكن تقريبية. نحن نعمل على تحسين ذلك — يرجى التحقق مع فريق التجربة قبل السفر.
  • Beatson West of Scotland Cancer Centre
    المدينة فقط
    Glasgow, Scotland

أسئلة شائعة

Will the higher dose of radiotherapy hurt during the session?

No. Radiotherapy itself is completely painless while it is being delivered, much like having an ordinary X-ray. Side effects such as a sore throat build up gradually over several weeks.

Can I choose whether I get the higher radiotherapy dose?

No. The decision is based strictly on what your two-week MRI scan shows. If your cancer is already shrinking well, a higher dose is not needed and would only cause unnecessary side effects.

What happens if I cannot tolerate the extra radiation?

Your safety comes first. The medical team tracks your symptoms closely. If side effects become too severe, your doctor can adjust your treatment plan or pause therapy to help you recover.

Do I have to pay for any of the extra scans or care?

No. All study scans, treatments, and appointments are provided through the NHS and funded by the research charity at no cost to you.

What is the difference between a normal MRI and the scan used in this trial?

The diffusion-weighted MRI used in this study looks at the microscopic movement of water in your cells. This gives doctors early clues about whether tumour cells are dying before changes can be seen on a standard scan.

كيفية معرفة المزيد

Ann Shaw

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.